272 related articles for article (PubMed ID: 21261172)
1. Extracorporeal photopheresis: a review on the immunological aspects and clinical applications.
Chiesa-Fuxench ZC; González-Chávez J
P R Health Sci J; 2010 Dec; 29(4):337-47. PubMed ID: 21261172
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photopheresis: what is it and when should it be used?
Scarisbrick J
Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
Fimiani M; Di Renzo M; Rubegni P
Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal photopheresis: from solid organs to face transplantation.
Hivelin M; Siemionow M; Grimbert P; Lantieri L
Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photochemotherapy--present and future.
Knobler R
Vox Sang; 2000; 78 Suppl 2():197-201. PubMed ID: 10938952
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photopheresis: past, present, and future.
Knobler R; Barr ML; Couriel DR; Ferrara JL; French LE; Jaksch P; Reinisch W; Rook AH; Schwarz T; Greinix H
J Am Acad Dermatol; 2009 Oct; 61(4):652-65. PubMed ID: 19665258
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis in chronic graft-versus-host disease.
Foss FM; Gorgun G; Miller KB
Bone Marrow Transplant; 2002 May; 29(9):719-25. PubMed ID: 12040467
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art.
Martino M; Fedele R; Cornelio G; Moscato T; Imbalzano L; Ressa G; Massara E; Bresolin G
Expert Opin Biol Ther; 2012 Aug; 12(8):1017-30. PubMed ID: 22587646
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis: a review.
Oliven A; Shechter Y
Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
[TBL] [Abstract][Full Text] [Related]
12. [Photopheresis: new immunomodulatory therapy for T-lymphocite mediated diseases].
Vagace Valero JM; Alonso Escobar N; De Argila Fernández-Durán D; Vargas Pérez L; Melero Ruiz J; Morán Penco JM; Bajo Gómez R; Pérez Miranda M
An Med Interna; 2003 Aug; 20(8):421-6. PubMed ID: 14516265
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
Child FJ; Ratnavel R; Watkins P; Samson D; Apperley J; Ball J; Taylor P; Russell-Jones R
Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
[TBL] [Abstract][Full Text] [Related]
14. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
Marshall SR
Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
16. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
Darvay A; Salooja N; Russell-Jones R
J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
[TBL] [Abstract][Full Text] [Related]
17. [Apheresis in dermatologic diseases].
Strangi RM; D'Ascenzo G; Bilenchi R; Trovato E; Sansica P; Gorgoglione V
G Ital Nefrol; 2012; 29 Suppl 54():S119-24. PubMed ID: 22388842
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
19. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
[TBL] [Abstract][Full Text] [Related]
20. Treatment of graft versus host disease (GVHD) by photopheresis?
Schooneman F; Claise C
Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]